The immunoassay market is projected to grow at a CAGR of 6% and to reach US$ 20 billion by 2027.
An Immunoassay is a chemical test used to detect or quantify a specific substance using an immunological reaction. Due to the use of antibodies and purified antigens, immunoassays are very sensitive and specific. The molecule detected by the immunoassay is often referred to as an analyte and is in many cases a protein, although it may be other kinds of molecules, of different size and types, as long as the proper antibodies that have the adequate properties for the assay are developed. Immunoassays are utilized in healthcare industry in applications such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, and neonatal screening.
This growth is primarily driven by the increasing incidences of chronic and infectious diseases, increasing use of immunoassay in oncology, rise in drug and alcohol testing, and technological advancement in immunoassay. In addition, emerging markets and increasing epidemic potentials offer significant growth opportunities for the players operating in this market. However, limitations of immunoassay and development of alternative technologies are expected to hinder the adoption of immunoassay products.
On the basis of product type, immunoassay kits and reagents segment accounted for the largest share of the overall immunoassay market in 2019. The large share of this segment is mainly attributed increasing number of immunoassay tests being performed across the globe leading to recurrent purchase of kits and reagents. Among kits and reagents, the ELISpot kits and reagents segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot assay kits and analyzers.
On the basis of detection technology or platform incorporated, the immunoassays market comprises Chemiluminescence Immunoassays (CLIAs), Colorimetric Immunoassays (CIs), Fluorescence Immunoassays (FIAs), Radioimmunoassays (RIAs), and other platforms, including turbidimetric immunoassays and counting immunoassays. The CLIAs segment accounted for the largest share of the overall immunoassay market in 2019. The large share of this segment can primarily be attributed to wide adoption of CLIAs in clinical diagnostics, research applications, and in pharmaceutical analysis due to low cost per test and high sensitivity.
On the basis of application, the immunoassay market is sub-segmented into infectious disease, endocrinology, oncology, bone & mineral diseases, cardiology, autoimmune diseases, allergy, and other diseases. Infectious diseases accounted for the largest share of the overall immunoassay market in 2019. The rising incidence of infectious diseases and growing adoption of immunoassay diagnostics in infectious diseases are the key factors attributed for the large share of this segment in this market. However, oncology segment is expected to grow at the highest CAGR during the forecast period. Rising prevalence of cancer, increasing focus towards tumor market development, technological advancements, and growing awareness about cancer are expected to drive the growth of this market.
On the basis of end user, the immunoassay market is segmented into hospitals and clinics, clinical laboratories, blood banks, research and academic laboratories, pharmaceutical and biotechnology companies, and other end users. The hospitals segment accounted for the largest share of the overall immunoassay market and is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the large volume of tests performed in hospitals and hospital-associated laboratories. Ease of access and need of faster turnaround time are some of the key factors that lead to large volume of tests performed in hospitals.
On the basis of geography, the immunoassay market is sub-segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the global immunoassay market in 2019. Rising incidence of chronic and infectious diseases, technological advancements in immunoassay instruments, growing focus towards point-of-care settings, and growth in the pharmaceutical and biotechnology industry are the key factors driving the growth of this market across the globe. While North America will continue to dominate the global immunoassay market, the APAC region is expected to grow at the highest CAGR during the forecast period of 2019 to 2027. The immunoassay market in Asia Pacific, especially in China, India, and Japan is expected to witness high growth during the forecast period. Growth in this market is expected to be driven by large pool of patient population, increasing prevalence of infectious diseases and cancer, increasing government spending on the healthcare, and growing disposable income of the population that improved the access to diagnosis and treatment. In addition, favourable government policies and healthcare structural reforms are further expected to drive the market growth. Furthermore, the lack of stringent regulations and liberalization in Asian countries is also a key factor making Asia Pacific a lucrative market.
The global immunoassay market is a highly consolidated in nature, wherein 5 major players — F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan) — accounted for major share of the global market. Other key players in this market are bioMérieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China).
Scope of Immunoassay Market Report:
Immunoassay Market by Product
Immunoassay Market by Platforms
Immunoassay Market by Application
Immunoassay Market by End User
Immunoassay Market by Geography
Immunoassay market favours both regional and local manufacturers that compete in multiple segments
Recent strategic developments taken place in the immunoassay market
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Immunoassay Market, By Technology
7.1. Immunoassay Market, By Technology, 2020-2028
7.1.1. Radioimmunoassay (RIA)
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Enzyme Immunoassay (EIA)
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Rapid test
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Immunoassay Market, By Product
8.1. Immunoassay Market, By Product, 2020-2028
8.1.1. Reagents & kits
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Analyzers/instruments
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Software & services
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Immunoassay Market, By End User
9.1. Immunoassay Market, by End User, 2020-2028
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Blood banks
9.1.2.1. Market Revenue and Forecast (2016-2028)
9.1.3. Clinical laboratories
9.1.3.1. Market Revenue and Forecast (2016-2028)
9.1.4. Pharmaceutical and biotech companies
9.1.4.1. Market Revenue and Forecast (2016-2028)
9.1.5. Academic research centers
9.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Immunoassay Market, By Application
10.1. Immunoassay Market, By Application, 2020-2028
10.1.1. Therapeutic drug monitoring
10.1.1.1. Market Revenue and Forecast (2016-2028)
10.1.2. Oncology
10.1.2.1. Market Revenue and Forecast (2016-2028)
10.1.3. Cardiology
10.1.3.1. Market Revenue and Forecast (2016-2028)
10.1.4. Endocrinology
10.1.4.1. Market Revenue and Forecast (2016-2028)
10.1.5. Infectious disease testing
10.1.5.1. Market Revenue and Forecast (2016-2028)
10.1.6. Autoimmune diseases
10.1.6.1. Market Revenue and Forecast (2016-2028)
Chapter 11. Global Immunoassay Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Technology (2016-2028)
11.1.2. Market Revenue and Forecast, By Product (2016-2028)
11.1.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.4. Market Revenue and Forecast, By Application (2016-2028)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.1.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.1.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Technology (2016-2028)
11.1.6.2. Market Revenue and Forecast, By Product (2016-2028)
11.1.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.1.6.4. Market Revenue and Forecast, By Application (2016-2028)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Technology (2016-2028)
11.2.2. Market Revenue and Forecast, By Product (2016-2028)
11.2.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.4. Market Revenue and Forecast, By Application (2016-2028)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.2.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.2.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Technology (2016-2028)
11.2.6.2. Market Revenue and Forecast, By Product (2016-2028)
11.2.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.6.4. Market Revenue and Forecast, By Application (2016-2028)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Technology (2016-2028)
11.2.7.2. Market Revenue and Forecast, By Product (2016-2028)
11.2.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.7.4. Market Revenue and Forecast, By Application (2016-2028)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Technology (2016-2028)
11.2.8.2. Market Revenue and Forecast, By Product (2016-2028)
11.2.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.2.8.4. Market Revenue and Forecast, By Application (2016-2028)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Technology (2016-2028)
11.3.2. Market Revenue and Forecast, By Product (2016-2028)
11.3.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.4. Market Revenue and Forecast, By Application (2016-2028)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.3.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.3.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Technology (2016-2028)
11.3.6.2. Market Revenue and Forecast, By Product (2016-2028)
11.3.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.6.4. Market Revenue and Forecast, By Application (2016-2028)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Technology (2016-2028)
11.3.7.2. Market Revenue and Forecast, By Product (2016-2028)
11.3.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.7.4. Market Revenue and Forecast, By Application (2016-2028)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Technology (2016-2028)
11.3.8.2. Market Revenue and Forecast, By Product (2016-2028)
11.3.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.3.8.4. Market Revenue and Forecast, By Application (2016-2028)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Technology (2016-2028)
11.4.2. Market Revenue and Forecast, By Product (2016-2028)
11.4.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.4. Market Revenue and Forecast, By Application (2016-2028)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.4.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.4.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Technology (2016-2028)
11.4.6.2. Market Revenue and Forecast, By Product (2016-2028)
11.4.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.6.4. Market Revenue and Forecast, By Application (2016-2028)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Technology (2016-2028)
11.4.7.2. Market Revenue and Forecast, By Product (2016-2028)
11.4.7.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.7.4. Market Revenue and Forecast, By Application (2016-2028)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Technology (2016-2028)
11.4.8.2. Market Revenue and Forecast, By Product (2016-2028)
11.4.8.3. Market Revenue and Forecast, by End User (2016-2028)
11.4.8.4. Market Revenue and Forecast, By Application (2016-2028)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Technology (2016-2028)
11.5.5.2. Market Revenue and Forecast, By Product (2016-2028)
11.5.5.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.5.4. Market Revenue and Forecast, By Application (2016-2028)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Technology (2016-2028)
11.5.6.2. Market Revenue and Forecast, By Product (2016-2028)
11.5.6.3. Market Revenue and Forecast, by End User (2016-2028)
11.5.6.4. Market Revenue and Forecast, By Application (2016-2028)
Chapter 12. Company Profiles
12.1. Siemens Healthineers
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Dickinson & Company
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. BioMérieux
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Abbott laboratories
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Roche Diagnostics
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Danaher Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ortho Clinical Diagnostics
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Sysmex Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. Quidel Corporation
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers